Olivier Geneste

This inventor holds 34 USPTO granted patents and 14 published patent applications, plus 19 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Les Laboratoires Servier, Vernalis &r&d) Ltd., Les Laboratories Servier. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Geneste. Retrieved from https://idiyas.com/inventor/olivier-geneste

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 34 (Patent Applications = 14)

% Patents Active = 85.3

CIPO Patents = 19 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 26)

Average Co-Inventor Count = 9.7

ph-index = 5

Forward Citations = 65(Granted Patents)

Company Filing History:

28 out of 296

Les Laboratoires Servier

Les Laboratories Servier

where one patent can have more than one assignee

Years Active: 2008-2022

Loading Chart...

Areas of Expertise:

MCL-1 Inhibitors

Pyrrole Compounds

Cancer Treatments

Isoindoline Compounds

Bcl-2 Family

Piperidine Derivatives

Thienopyrimidine Derivatives

Aminoacid Derivatives

Hydroxyester Derivatives

Indole Compounds

Peptide Interactions

Pharmaceutical Compositions

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11466023 - Combination of a Mcl-1 inhibitor and a standard of care treatment for hematologic cancers, uses and pharmaceutical compositions thereof (2022-10-11),

2. 11332472 - Substituted piperidines as inhibitors of ubiquitin specific protease 7 (2022-05-17),

3. 11058689 - Pyrrole compounds, a process for their preparation and pharmaceutical (2021-07-13),

4. 11046681 - Substituted piperidines for the treatment of cancer (2021-06-29),

5. 11028070 - Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them (2021-06-08),

6. 10765680 - Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof (2020-09-08),

7. 10711010 - Hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them (2020-07-14),

8. 10689364 - Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them (2020-06-23),

9. 10688101 - Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them (2020-06-23),

10. 10662173 - Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them (2020-05-26),

11. 10654849 - (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them (2020-05-19),

12. 10618909 - Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them (2020-04-14),

13. 10457689 - Ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them (2019-10-29),

14. 10457687 - Aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them (2019-10-29),

15. 10414754 - Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them (2019-09-17),

Title: The Innovative Journey of Olivier Geneste

Introduction: Olivier Geneste, a visionary inventor hailing from Rueil-Malmaison, France, has made significant contributions to the world of technology and innovation.

Latest Patents: Olivier Geneste holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the renewable energy sector, Olivier Geneste has led research teams in developing cutting-edge solutions for sustainable energy production. His work has been instrumental in advancing the adoption of clean energy technologies globally.

Collaborations: Throughout his career, Olivier Geneste has collaborated with leading research institutions and universities to further his research in renewable energy. His partnerships have resulted in innovative projects that have pushed the boundaries of sustainable technology.

Conclusion: Olivier Geneste's passion for innovation and commitment to sustainability have established him as a pioneering figure in the field of renewable energy. His continued dedication to creating a greener future serves as an inspiration to aspiring inventors and researchers worldwide.

Profile summary based on public USPTO records.